1.Amano T, Yokota C, Sakamoto Y, Shigehatake Y, Inoue Y, Ishigami A, Hagihara T, Tomii Y, Miyashita F, Toyoda , Minematsu K:

Stroke Education Program of Act FAST for Junior High School Students and Their Parents.

J Stroke Cerebrovasc Dis, 

2.Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F:

Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Orphanet J Rare Dis, 8: 31, 2013

3.Abdihalim M, Watanabe M, Chaudhry SA, Jagadeesan B, Suri MF, Qureshi AI:

Are coil compaction and aneurysmal growth two distinct etiologies to recurrence following endovascular treatment of intracranial aneurysm.

J Neuroimaging, 24: 171-175, 2013

4.Alqadri S, Adil MM, Watanabe M, Qureshi AI:

Patterns of collateral formation in basilar artery steno-occlusive diseases.

J Vasc Interv Neurol, 6: 9-13, 2013

5.Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ;Diflunisal Trial Consortium:

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

10: 2658-2667, 2013

6.Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, Roy A, Chamova T, Guergueltcheva V, Korngut L, Campbell C, Dai Y, Barisic N, Kos T, Brabec P, Rahbek J, Lahdetie J, Tuffery-Giraud S, Claustres M, Leturcq F, Ben Yaou R, Walter MC, Schreiber O, Karcagi V, Herczegfalvi A, Viswanathan V, Bayat F, de la Caridad Guerrero Sarmiento I, Ambrosini A, Ceradini F, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Oliveira J, Santos R, Neagu E, Butoianu N, Artemieva S, Rasic VM, Posada M, Palau F, Lindvall B, Bloetzer C, Karaduman A, Topaloglu H, Inal S, Oflazer P, Stringer A, Shatillo AV, Martin AS, Peay H, Flanigan KM, Salgado D, von Rekowski B, Lynn S, Heslop E, Gainotti S, Taruscio D, Kirschner J, Verschuuren J, Bushby K, Beroud C, Lochmuller H:

The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.

Hum mutat, 34: 1449-1457, 2013

7.Chaudhry SA, Tariq N, Majidi S, Afzal MR, Hassan AE, Watanabe M, Rodriguez GJ, Suri MF, Hussain S, Qureshi AI:

Rates and factors associated with admission in patients presenting to the ED with TIA in the United States-2006 to 2008.

Am J Emerg Med, 31: 516-519, 2013

8.Field TS, Nakajima M, Benavente OR:

Combination aspirin and clopidogrel for secondary prevention of ischemic stroke.

Curr Treat Options Cardiovasc Med, 15: 348-359, 2013

9.Hayashi Y, Higashi T, Motoyama K, Mori Y, Jono H, Ando Y, Arima H:

Design and evaluation of polyamidoamine dendrimer conjugate with PEG, a-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.

J Drug Target, 21: 487-496, 2013

10.Hayashi M, Jono H, Shinriki S, Nakamura T, Guo J, Sueta A, Tomiguchi M, Fujiwara S, Yamamoto-Ibusuki M, Murakami KI, Yamashita S, Yamamoto Y, Li JD, Iwase H, Ando Y:

Clinical significance of CYLD downregulation in breast cancer.

Breast Cancer Res Treat, 143: 447-457, 2014

11.Hirahara T, Yamashita S, Misumi Y, Kawakami K, Hori H, Honda S, Watanabe M, Ikeda T, Yamashita T, Maeda Y, Ando Y: 

Gait Disturbance due to Foot Drop Is Refractory to Treatment in Nonsystemic Vasculitic Neuropathy.

Eur Neurol, 71: 180-186, 2014

12. Honda S, Inatomi Y, Yonehara T, Hashimoto Y, Hirano T, Ando Y, Uchino M:

Discrimination of Acute Ischemic Stroke from Nonischemic Vertigo in Patients Presenting with Only Imbalance.

J Stroke Cerebrovasc Dis,  2014

13.Ihse E, Rapezzi C, Merlini G, Benson M, Ando Y, Suhr O, Ikeda SI, Lavatelli F, Obici L, Quarta C, Leone O, Jono H,Ueda M, Lorenzini M, Liepnieks J, Ohshima T, Tasaki M, Yamashita T, Westermark P: 

Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.

Amyloid, 20: 142-150, 2013

14.Inatomi Y, Nakajima M, Yonehara T, Hirano T:

Contralateral recurrence of carotidynia during steroid therapy.

J Stroke Cerebrovasc Dis, 23: 184-186, 2014

15.Isono K, Jono H, Ohya Y, Shiraki N, Yamazoe T, Sugasaki A, Era T, Fusaki N, Tasaki M, Ueda M, Shinriki S, Inomata Y, Kume S, Ando Y:

Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.

Stem Cell Res, 12: 574-583, 2014

16.Imada Y, Tokunaga M, Fukunaga K, Sannomiya K, Inoue R, Hamasaki H, Noguchi D, Nakashima Y, Watanabe S, Nakanishi R, Yamanaga H:

Relationship between cognitive FIM score and motor FIM gain in patients with stroke in a Kaifukuki rehabilitation ward.

Jpn J Compr Rehabil Sci, 5: 12-18, 2014

17.Inoue Y, Watanabe M, Ando Y:

Brain Infarction with a Predilection for Cerebellum in a Patient with Double-Outlet Left Ventricle and Vascular Malformations.

J Stroke Cerebrovasc Dis, 2014

18.Inoue Y, Miyashita F, Toyoda K, Minematsu K:

Low serum calcium levels contribute to larger hematoma volume in acute intracerebral hemorrhage.

Stroke, 44: 2004-2006, 2013

19.Inoue Y, Miyashita F, Koga M, Yamada N, Toyoda K, Minematsu K:

Panmedullary edema with inferior olivary hypertrophy in bilateral medial medullary infarction.

J Stroke Cerebrovasc Dis, 23: 554-556, 2014

20.Kawano H, Hirano T, Inatomi Y, Terasaki T, Yonehara T, Uchino M:

Hyperacute-Phase Computed Tomography-Diffusion-Weighted Imaging Discrepancy and Response to Thrombolysis.

J Stroke Cerebrovasc Dis, 22: 290-296, 2013

21.Kawano H, Inatomi Y, Hirano T, Yonehara T:

Vertebral artery stump syndrome in acute ischemic stroke.

J Neurol Sci, 324: 74-79, 2013

22.Kawano H, Hirano T, Inatomi Y, Yonehara T:

Cerebral infarction in both carotid and vertebrobasilar territories associated with a persistent primitive hypoglossal artery with severe dilated cardiomyopathy.

J Stroke Cerebrovasc Dis, 23: 176-178,2014

23.Kawano H, Nakajima M, Inatomi Y, Yonehara T, Ando Y:

Loading dose of clopidogrel in combination with other antithrombotic therapy for capsular warning syndrome.

J Stroke Cerebrovasc Dis, 2014 in press

24.Kawano H, Hirano T, Nakajima M, Inatomi Y, Yonehara T:

Diffusion-weighted MR imaging may underestimate acute ischemic lesions – Cautions on neglecting a CT – DWI discrepancy.

Stroke, 44: 1056-1061, 2013

25. Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, Mima K, Nakagawa S, Yokoyama N, Ishiko T, Shinriki S, Jono H, Ando Y, Baba H:

CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma.

Molecular Clin Oncol, 18: 19-24, 2013

26.Kosaka T, Kuroha Y, Tada M, Hasegawa A, Tani T, Matsubara N, Koike R, Toyoshima Y, Takahashi H:

A fatal neuromuscular disease in an adult patient after poliomyelitis in early childhood: Consideration of the pathology of post-polio syndrome:

Neuropathology, 33: 93-101, 2013

27.Kuronuma Y, Suzuki R, Inoue Y, Miyashita F, Toyoda K:

Anterior inferior cerebellar artery territorial infarction caused by vertebral artery dissection.

Cerebrovasc Dis, 35:592, 2013

28.Matsuo Y, Yamashita S, Honda S, Nakajima M, Ueda A, Hirahara T, Yamashita T, Maeda Y, Hirano T, Ando Y:

Bilateral basal ganglia lesions as initial manifestation of CNS invasion in adult T-cell leukemia.

J Neurol Sci, 327: 63-64, 2013

29. Majidi S, Hassan A, Watanabe M, Sein J, Van de Moortele PF, Clark HB, Suri F, Qureshi AI:

Intracranial derived atherosclerosis assessment: An in-vitro comparison between virtual histology by intravascular ultrasonography, 7-Tesla MRI and histopathological findings.

AJNR, 34: 2259-2264, 2013

30.Misumi Y, Ando Y, Gonçalves NP, Saraiva MJ:

Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.

Lab Invest, 93: 911-920, 2013

31.Miyashita F, Yokota C, Nishimura K, Amano T, Inoue Y, Shigehatake Y, Sakamoto Y, Tani S, Narazaki H, Toyoda K, Nakazawa K, Minematsu K:

The Effectiveness of a Stroke Educational Activity Performed by a Schoolteacher for Junior High School Students.

J Stroke Cerebrovasc Dis, 2014

32.Nakajima M, Inatomi Y, Yonehara T, Okigawa T, Hirano T:

Secondary signal change and an apparent diffusion coefficient decrease of the substantia nigra following striatal infarction．

Stroke, 44: 213-216, 2013

33.Nakajima M, Inatomi Y, Yonehara T, Hirano T, Ando Y:

Nontraumatic Convexal Subarachnoid Hemorrhage Concomitant with Acute Ischemic Stroke.

J Stroke Cerebrovasc Dis, 2014

34.Nakajima M, Inatomi Y, Yonehara T, Terasaki T, Ando Y:

Frequent ischemic events related to varying middle cerebral artery stenosis.

Intern Med, 53: 797-800, 2014

35.Nakajima M, Inatomi Y, Yonehara T, Hashimoto Y, Hirano T, Ando Y:

Temporal trends in oral intake ability 3 months after acute ischaemic stroke: Analysis of a single-centre database from 2003 to 2011.

J Rehabil Med, 46: 200-205, 2014

36.Nakahara K, Yamashita S, Ideo K, Shindo S, Suga T, Ueda A, Honda S, Hirahara T, Watanabe M, Yamashita T, Maeda Y, Yonemochi Y, Takita T, Ando Y:

Drastic therapy for listerial brain abscess by combination of hyperbaric oxygen therapy and antimicrobial agents.

J Clin Neurol, 2014

37.Nakamura H, Kimura E, Mori-Yoshimura M, Komaki H, Matsuda Y, Goto K, Hayashi YK, Nishino I, Takeda SI, Kawai M:

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).

Orphanet J Rare Dis, 8: 60, 2013

38.Nakamura T, Migita K, Ando Y, Takaoka H, Suzushima H, Shiraishi N:

Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I.

Mod Rheumatol, 24: 349-352, 2014

39.Nakazono M, Obayashi K, Sasamoto K, Tomiyoshi K, Suenaga G, Ando Y:

Novel styrylbenzene derivatives for detecting amyloid deposits.

Clin Chim Acta, 2014

40.Nakazono M, Obayashi K, Oshikawa Y, Tani K, Suenaga G, Ando Y, Nanbu S, Kuwano R:

Unsymmetric indolylmaleimides: synthesis, photophysical property and amyloid detection.

J Photochem Photobiol A, 2014

41.Naganuma M, Isoda K, Nishi S, Ito K, Hirano T:

Repeated episodes of ischemic stroke over a short period in a patient with essential thrombocythemia on anticoagulant therapy.

J Stroke Cerebrovasc Dis, 23: 166-168, 2014

42.Obayashi K, Misumi Y, Watanabe T, Ando T, Akagami T, Tasaki M, Shinriki S, Ueda M, Yamashita T, Hirotani S, Ando Y:

Dominant cardiac type of familial amyloidotic polyneuropathy associated with a novel transthyretin variant Thr59Arg.

Muscle Nerve, 48: 839-841, 2013

43. Obayashi K, Tasaki M, Jono H, Ueda M, Shinriki S, Misumi Y, Yamashita T, Oshima T, Nakamura T, Ikemizu S, Anan I, Suhr O, Ando Y:

Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.

Clin Chim Acta, 419: 127-131, 2013

44.Ogasawara N, Kitagawa W, Obayashi K, Itoh Y, Noda H, Funaki Y, Yokoi T, Sasaki M, Imai H, Kasugai K:

Solitary amyloidosis of the sigmoid colon featuring submucosal tumor caused hematochezia.

Intern Med, 52: 2523-2527, 2013

45.Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi T, Asonuma K, Ando Y, Inomata Y:

Peritransplant Gastrointestinal Symptoms in Familial Amyloidotic Polyneuropathy.

Exp Clin Transplant, 11: 327-331, 2013

46.Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y:

Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.

J Neurol Neurosurg Psychiatry, 2014

47.Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, DiFrancesco JC:

Anti-Aβ autoantibodies in Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-modifying therapies.

Annals of Neurology, 73: 449-458, 2013

48.Qureshi AI, Chaudhry SA, Connelly B, Abott E, Janjua T, Kim SH, Miley JT, Rodriguez GJ, Uzun G, Watanabe M:

Impact of advanced health care directives on treatment decisions by physicians in patients with acute stroke.

Crit Care Med, 41: 1468-1475, 2013

49.Sakaguchi H, Yamashita S, Suga T, Kimura E, Maeda Y, Hirano T, Uchino M:

Multiple system atrophy in a patient with primary ciliary dyskinesia.

Neurology Asia, 18: 103-105, 2013

50.Sakashita N, Kagawa S, Date R, Ueno T, Nakagawa T, Yamashita T, Obayashi K, Ohshima T, Ueda M, Horiguchi H, Ando Y, Takeya M:

Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.

Pathol Int, 63: 260-265, 2013

51.Shigehatake Y, Yokota C, Amano T, Tomii Y, Inoue Y, Hagihara T, Toyoda K, Minematsu K:

Stroke Education Using an Animated Cartoon and a Manga for Junior High School Students.

J Stroke Cerebrovasc Dis, 2014

52.Shinriki S, Jono H, Ueda M, Obayashi K, Nakamura T, Ota K, Ota T, Sueyoshi T, Guo J, Hayashi M, Hiraki A, Nakayama H, Yamashita S, Shinohara M, Ando Y:

Stromal Expression of Neutrophil Gelatinase-Associated Lipocalin Correlates with Poor Differentiation and Adverse Prognosis in Oral Squamous Cell Carcinoma.

Histopathology, 64: 356-364, 2014

53.Honda S, Inatomi Y, Yonehara T, Hashimoto Y, Hirano T, Ando Y, Uchino M:

Discrimination of acute ischemic stroke from non-ischemic vertigo in patients with a feeling of imbalance only.

Journal of Stroke and Cerebrovascular, 2013

54.Somekawa-Kondo T, Yamaguchi K, Ishitsuka Y, Itoa S, Tanaka K, Irikura M, Moriuchi H, Takahama K, Ando Y, Yamasaki T, Irie T:

Aminophylline, administered at usual doses for rodents in pharmacological studies, induces hippocampal neuronal cell injury under low tidal volume hypoxic conditions in guinea pigs.

J Pharm Phatmacol, 65: 102-114, 2013

55.Takechi U, Matsunaga K, Nakanishi R, Yamanaga H, Murayama N, Mafune K, Tsuji S:

Longitudinal changes of motor cortical excitability and transcallosal inhibition after subcortical stroke.

Clin Neurophysiol, 2014

56.Takeuchi F, Yonemoto N, Nakamura H, Shimizu R, Komaki H, Mori-Yoshimura M, Hayashi YK, Nishino I, Kawai M, Kimura E, Takeda S:

Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients.

J Neurol, 260: 3023-3029, 2013

57.Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe KI, Kimura E, Sakurai H:

Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro.

PLoS One, 8: e61540, 2013

58.Tasaki M, Ueda M, Obayashi K, Koike H, Kitagawa K, Ogi Y, Jono H, Su Y, Suenaga G, Oshima T, Misumi Y, Yoshida M, Yamashita T, Sobue G, Ando Y:

Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach.

Int J Cardiol, 170: 69-74, 2013

59.Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y,  Otagiri M:

Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.

Life Scim 93: 1017-1022, 2013

60.Tawara S, Yonemochi Y, Kosaka T, Kouzaki Y, Takita T, Tsuruta T:

Use of Patients’ Mobile Phones to Store and Share Personal Health Information: Results of a Questionnaire Survey.

Internal Medicine, 52: 751-756, 2013

61.Tokunaga M, Fukunaga K, Sannomiya K, Imada Y, Hamasaki H, Noguchi D, Nakashima Y, Watanabe S, Nakanishi R, Yamanaga H:

The difference between measured Nichijo-seikatsu-kino-hyokahyo (NSKH) score and predicted NSKH score derived from ADL is related to FIM gain.

Jpn J Compr Rehabil Sci, 4: 61-66, 2013

62.Tokunaga M, Nakanishi R, Watanabe S, Maeshiro I, Hyakudome A, Sakamoto K, Okubo T, Nojiri S, Yamanaga H:

Corrected FIM effectiveness as an index independent of FIM score on admission.

Jpn J Compr Rehabil Sci, 5: 7-11, 2014

63.Tokunaga M, Fukunaga K, Nakanishi R, Watanabe S, Yamanaga H:

A patient of midbrain infarction causing oculomotor nerve palsy and ipsilateral cerebellar ataxia.

Internal Medicine, 

64.Tokunaga M, Watanabe S, Terasaki T, Takita T, Yonehara T, Nishi T, Kanazawa C, Kawano S, Yamakuma K, Yamaga M, Hashimoto Y:

A study of standard criteria for hospital admission fees using the Nichijo-seikatsu-kino-hyokahyo in Kaifukuki rehabilitation wards.

Jpn J Compr Rehabil Sci, 

65.Tokunaga M, Sannomiya K, Ohashi T, Yonemura M, Sakata D, Imaya M, Sugitani E, Mitsunaga W, Shiiba S, Nakashima Y:

Three different methods for demonstrating that gain in Functional Independence Measure increases with higher cognitive ability.

Jpn J Compr Rehabil Sci, 

66.Uchino M, Yamashita S, Uchino K, Mori A, Hara A, Suga T, Hirahara T, Koide K, Kimura E, Yamashita T, Ueda A, Kurisaki R, Suzuki J, Honda S, Maeda Y, Hirano T, Ando Y

Muscle biopsy findings predictive of Malignancy in rare infiltrative dermatomyositis.

Clin Neurol Neurosurg, 115: 603-606, 2013

67. Uemura M, Kosaka T, Shimohata T, Ishikawa M, Nishihira Y, Toyoshima Y, Yanagawa K, Kawachi I, Takahashi H, Nishizawa M:

Dropped head syndrome in amyotrophic lateral sclerosis.: Amyotroph Lateral Scler Frontotemporal Degener, 14: 232-233, 2013

68.Usuku H, Obayashi K, Shono M, Oshima T, Tasaki M, Yasuda H, Ogawa H, Ando Y:

Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy.

Amyloid, 20: 251-255, 2013

69.Usuku H, Izumiya Y, Sugiyama S, Kojima S, Araki S, Kurogi K, Yamamoto N, Ando Y, Ogawa H:

Lower Framingham risk score and the absence of hypertension are associated with the morning peak in the circadian variation of ST-elevation myocardial infarction onset.

Hypertens Res, 2014

70.Watanabe M, Qureshi AI:

Are CT angiography source images accurate for evaluating infarct volume?

J Neuroimaging, 23: 163-164, 2013

71.Watanabe M, Kai Y, Hirano T, Ohmori Y, Kazekawa K, Kuratsu J:

Manual external carotid artery manipulation for failed device advance through the stent in carotid artery stent placement.

A technical note. J Vasc Interv Neurol, 6: 52-55, 2013

72.Watanabe M, Semaan E, Majidi S, Chaudhry SA, Adil MM, Alqadri S, Qureshi AI:

Treatment of cerebral dural sinus stenosis using stent placement: a systematic review.

J Vasc Interv Neurol, 2014

73.Watanabe M, Majidi S, Chaudhry SA, Qureshi AI:

The severity of intracranial stenosis in anterior circulation correlates with asymmetrical hemispheric cerebral volume on magnetic resonance imaging.

J Vasc Interv Neurol, 2014

74.Watari M, Nakajima M, Nishitomi-Izumida M, Inatomi Y, Yonehara T, Hirano T:

Dynamic migration of a mobile plaque from the brachiocephalic artery detected by ultrasonography.

Echocardiography, 30:E28-29, 2013

75.Wixner J, Obayashi K, Ando Y, Karling P, Anan I:

Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Amyloid, 20: 99-106, 2013

76.Yumura A, Hokazono E, Ikeda K, Obayashi K, Ando Y, Osawa S:

Development of the enzymatic assay for whole blood choline using an automated biochemical analysis.

Int J Anal Bio-Sci, 2014

77.Yamashita S, Kimura E, Tawara N, Sakaguchi H, Nakama T, Maeda Y, Hirano T, Uchino M, Ando Y:

Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.

Neuropatho Appl Neurobiol, 39: 406-416, 2013

78.Yamashita S, Fujimoto A, Mori A, Hirahara T, Mori A, Hirano T, Maeda Y, Uchino M, Ando Y:

Coexistence of amyotrophic lateral sclerosis and myasthenia gravis.

Journal of Neuromuscular Diseases, 2014

79.Yokoseki A, Saji E, Arakawa M, Kosaka T, Hokari M, Toyoshima Y, Okamoto K, Takeda S, Sanpei K, Kikuchi H, Hirohata S, Akazawa K, Kakita A, Takahashi H, Nishizawa M, Kawachi I:

Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.

Brain, 137: 520-536, 2014

80.Yoshizawa T, Karim MF, Sato Y, Senokuchi T, Miyata K, Fukuda T, Go C, Tasaki M, Uchimura K, Kadomatsu T, Tian Z, Smolka C, Sawa T, Takeya M, Tomizawa K, Ando Y, Araki E, Akaike T, Braun T, Oike Y, Bober E, Yamagata K:

SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway.

Cell Metab,